CATHAY BIOTECH INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.33 CNY | -2.09% |
|
-3.65% | -12.10% |
| Apr. 29 | Cathay Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 15 | Cathay Biotech's Q1 Profit to Surge Up to 100%, Revenue to Climb 43%; Shares Up 6% | MT |
ETFs positioned on Cathay Biotech Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.69% | 1 M€ | -15.68% | - | |
| 0.81% | 45 M€ | -15.31% | - | |
| 0.81% | 45 M€ | -15.11% | - | |
| 0.81% | 38 M€ | -13.75% | - | |
| 0.00% | 34 M€ | +4.49% | - |
Cathay Biotech Inc is a China-based company engaged in research, development, production and sales of biobased materials. The Company's primary products are biological long-chain dibasic acids and bio-based polyamide series, including lauric acid and brazilian acid, which are used in long-chain polyamides, fragrances, hot melt adhesives, lubricants, powder coatings and other areas. The Company sells its products to domestic and overseas markets.
Sector
Specialty Chemicals
Calendar
2024-08-07
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -12.10% | 3.96B | |
| +13.69% | 29B | |
| +13.19% | 1.92B | |
| -0.92% | 607M | |
| -19.44% | 431M | |
| -81.65% | 216M | |
| -10.14% | 56.56M |
- Stock Market
- Equities
- 688065 Stock
- Funds and ETFs Cathay Biotech Inc.
